3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
5
Gynecologic
1
Genitourinary
1
Conditions
Prostatic Neoplasms
64
Breast Neoplasms
15
Urinary Bladder Neoplasms
12
Colorectal Neoplasms
9
Carcinoma, Renal Cell
8
Kidney Neoplasms
7
Lung Neoplasms
6
Neoplasm Metastasis
4
Gastrointestinal Neoplasms
4
Testicular Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Urogenital Neoplasms
2
Urinary Incontinence
2
Head and Neck Neoplasms
2
Erectile Dysfunction
2
Disease
2
Depression
2
Carcinoma, Transitional Cell
2
Anxiety Disorders
2
Adenocarcinoma
2
Wilms Tumor
1
Vomiting
1
Varicocele
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Abnormalities
1
Urinary Bladder, Overactive
1
Thyroid Neoplasms
1
Interventions
Psychiatric Rehabilitation
3
Counseling
3
Sildenafil Citrate
2
Radiotherapy
2
High-Intensity Focused Ultrasound Ablation
2
methyl N-acetylsibirosaminide
1
methyl 3-mercaptopropionimidate
1
bicalutamide
1
Tadalafil
1
Surveys and Questionnaires
1
Restraint, Physical
1
Radiosurgery
1
Prostatectomy
1
Phentolamine
1
Papaverine
1
Menogaril
1
Magnetic Resonance Spectroscopy
1
Leuprolide
1
Goserelin
1
Flutamide
1
Finasteride
1
Family Characteristics
1
Diet Therapy
1
Cognitive Behavioral Therapy
1
Chemotherapy, Adjuvant
1
Biopsy
1
Biofeedback, Psychology
1
Alprostadil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sexual Dysfunction, Physiological
×
Surveys and Questionnaires
×
Genitourinary
×
Clear all
NCT04964895
2025-12-17
QSCO
University Hospital, Toulouse
Completed
50 enrolled